Location History:
- Tokushima, JP (1980)
- Nishinomiya, JP (1981 - 1982)
Company Filing History:
Years Active: 1980-1982
Title: Daisuke Satoh: Innovator in Pharmaceutical Chemistry
Introduction
Daisuke Satoh is a prominent inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with anti-tumor and immunosuppressive properties. With a total of 4 patents to his name, Satoh continues to push the boundaries of innovation in his field.
Latest Patents
One of Satoh's latest patents involves the creation of pyrrolo-benzodiazepine compounds and their anti-tumor compositions. These novel compounds, specifically the 5,10,11,11a-tetrahydro-8-methyl-11-sulfo or sulfino-1H-pyrrolo[2,1-c][1,4]-benzodiazepin-2-acrylamides, exhibit antitumor activity while maintaining low toxicity. The preparation process includes reacting a corresponding 11-reactive compound with a reactive sulfur compound to form 11-sulfino compounds, which can be oxidized to obtain 11-sulfo compounds.
Another significant patent focuses on the preparation of cholesterol derivatives. This innovation involves new organic dibasic acid half esters of 7-ketocholesterol and 7-hydroxycholesterol, which are represented by a specific general formula. These compounds are recognized for their effectiveness as immunosuppressive or anti-inflammatory agents.
Career Highlights
Daisuke Satoh is currently associated with The Green Cross Corporation, where he applies his expertise in pharmaceutical research and development. His work has been instrumental in advancing the understanding and application of various chemical compounds in medicine.
Collaborations
Throughout his career, Satoh has collaborated with notable colleagues, including Yasuo Ueda and Yoshio Kagitani. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Daisuke Satoh's contributions to pharmaceutical chemistry through his innovative patents highlight his commitment to advancing medical science. His work continues to impact the field positively, paving the way for future developments in anti-tumor and immunosuppressive therapies.